悉复欢片治疗细菌性感染35例  

CIFRAN IN TREATING 35 PATIENTS WITH BACTERIAL INFECTIONS

作　　者：徐楠[1] 梁德荣[1] 张慧琳[1] 张辉明[1] 

机构地区：[1]华西医科大学临床药理研究所

出　　处：《中国新药杂志》1995年第3期25-27,共3页Chinese Journal of New Drugs

摘　　要：口服悉复欢（环丙沙星）治疗呼吸道、泌尿道、消化道及其它急性细菌性感染患者３５例，临床总有效率为８８．６％，细菌清除率为８４．８％，不良反应发生率３／３５；与阳性对照药泰利必妥比较，试验药与对照药的临床总有效率、细菌清除率及不良反应发生率均无显著性差异。结果表明，悉复欢是一抗菌力强，抗菌谱广，疗效可靠，使用安全的抗菌药物。In order to evaluate the theraputic efficacy and safety of oral cifran,a randomized controlled study was conducted on 35 patients with various bac-terial infections using Tarivid as control. The results of the study showed that no sta-tistically significant differences exist between Cifran and Tarivid in respect of total ef-fective rate, bacterial clearence rate and side-effect rate.

关 键 词：环丙沙星 悉复欢 细菌感染 

分 类 号：R515.05[医药卫生—内科学] R978.19[医药卫生—临床医学]